Literature DB >> 9428015

Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis.

E W Ng1, N Samiy, J B Rubins, F V Cousins, K L Ruoff, A S Baker, D J D'Amico.   

Abstract

PURPOSE: To determine if pneumolysin, a multifunctional cytotoxin produced by Streptococcus pneumoniae, may be a virulence determinant in the pathogenesis of pneumococcal endophthalmitis.
METHODS: Lewis rats (n = 20) were injected intravitreally with purified recombinant pneumolysin at the following doses; 3.9 hemolytic units (HU), 39 HU, 390 HU, 3.9 x 10(3) HU, and 3.9 x 10(4) HU. After 24 hours, eyes were examined clinically and enucleated for histopathologic examination to elucidate the dose-response relationship. To determine the temporal progression of the disease model, a second group of rats (n = 8) were injected intravitreally with 390 HU of pneumolysin. At 6 and 48 hours, eyes were examined clinically and enucleated for histopathology.
RESULTS: Eyes injected with pneumolysin demonstrated increasing anterior and posterior segment inflammation in response to increasing doses of administered toxin. The onset of inflammation and tissue damage occurred rapidly, and was maximal at 24 to 48 hours. The clinical and histopathologic changes observed mimicked those of S. pneumoniae endophthalmitis. Histopathologic analysis demonstrated rapid onset of iridocyclitis and vitritis with polymorphonuclear leukocyte influx, inner retinal necrosis, and retinal detachment. Retinal pigment epithelial necrosis and choroiditis were noted at the highest doses administered. Inflamed eyes were shown to be sterile.
CONCLUSIONS: Pneumolysin injected intravitreally induces many of the clinical and histopathologic features of pneumococcal endophthalmitis, and may play an important role in the inflammation and tissue damage that occurs in pneumococcal endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9428015

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  19 in total

1.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

Review 2.  Targets of immunomodulation in bacterial endophthalmitis.

Authors:  Frederick C Miller; Phillip S Coburn; Mursalin Md Huzzatul; Austin L LaGrow; Erin Livingston; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2019-05-28       Impact factor: 21.198

3.  The Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Zachary M Robertson; Quincy C Moore; Jonathan Fratkin; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

Review 4.  Modeling intraocular bacterial infections.

Authors:  Roger A Astley; Phillip S Coburn; Salai Madhumathi Parkunan; Michelle C Callegan
Journal:  Prog Retin Eye Res       Date:  2016-05-03       Impact factor: 21.198

5.  Differential bacterial gene expression during experimental pneumococcal endophthalmitis.

Authors:  Justin A Thornton; Nathan A Tullos; Melissa E Sanders; Granger Ridout; Yong-Dong Wang; Sidney D Taylor; Larry S McDaniel; Mary E Marquart
Journal:  Ophthalmic Res       Date:  2015-03-12       Impact factor: 2.892

6.  Pathogenesis of A Clinical Ocular Strain of Streptococcus pneumoniae and the Interaction of Pneumolysin with Corneal Cells.

Authors:  Erin W Norcross; Melissa E Sanders; Quincy C Moore; Mary E Marquart
Journal:  J Bacteriol Parasitol       Date:  2011

7.  Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

Authors:  Dennis P Han
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis.

Authors:  Michelle C Callegan; Daniel C Cochran; Scott T Kane; Michael S Gilmore; Myriam Gominet; Didier Lereclus
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Pneumolysin released during Streptococcus pneumoniae autolysis is a potent activator of intracellular oxygen radical production in neutrophils.

Authors:  Anna Martner; Claes Dahlgren; James C Paton; Agnes E Wold
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

10.  Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Sidney Taylor; Nathan Tullos; Erin W Norcross; Quincy C Moore; Hilary Thompson; Lauren B King; Mary E Marquart
Journal:  BMC Ophthalmol       Date:  2013-03-11       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.